Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florentia Dimitriou

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Melanoma Research|March 15, 2019
Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanomaJoanna Mangana, Florentia Dimitriou, Ralph Braun, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanomaFlorentia Dimitriou, Ursula Urner-Bloch, Corinne Eggenschwiler, et al.
Current Oncology Reports|September 26, 2018
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the GlobeFlorentia Dimitriou, Regina Krattinger, Egle Ramelyte, et al.
ESC Heart Failure|April 6, 2023
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?Valentina A Rossi, Joanna Gawinecka, Florentia Dimitriou, et al.
Pathology|August 23, 2021
Cutaneous clear cell sarcoma with an epidermal component mimicking melanomaAlison J Potter, Florentia Dimitriou, Rooshdiya Z Karim, et al.
Oncotarget|June 6, 2019
Melanoma patients with additional primary cancers: a single-center retrospective analysisFlorentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, et al.
Melanoma Research|December 10, 2024
Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanomaBita Esmaeli, Tyler Ogden, Matthew Nichols, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2018
Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic MelanomaFlorentia Dimitriou, Alexandra V Matter, Joanna Mangana, et al.
European Journal of Dermatology : EJD|April 7, 2020
Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphomaAnja Moczko, Florentia Dimitriou, Hanna Kresbach, et al.
Oncoimmunology|March 1, 2021
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndromeChristoph Iselin, Yun-Tsan Chang, Tanja Schlaepfer, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Melanoma Research|March 15, 2019
Single-center real-life experience with low-dose ipilimumab monotherapy in adjuvant setting for patients with stage III melanomaJoanna Mangana, Florentia Dimitriou, Ralph Braun, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2020
The association between immune checkpoint or BRAF/MEK inhibitor therapy and uveitis in patients with advanced cutaneous melanomaFlorentia Dimitriou, Ursula Urner-Bloch, Corinne Eggenschwiler, et al.
Current Oncology Reports|September 26, 2018
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the GlobeFlorentia Dimitriou, Regina Krattinger, Egle Ramelyte, et al.
ESC Heart Failure|April 6, 2023
Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?Valentina A Rossi, Joanna Gawinecka, Florentia Dimitriou, et al.
Pathology|August 23, 2021
Cutaneous clear cell sarcoma with an epidermal component mimicking melanomaAlison J Potter, Florentia Dimitriou, Rooshdiya Z Karim, et al.
Oncotarget|June 6, 2019
Melanoma patients with additional primary cancers: a single-center retrospective analysisFlorentia Dimitriou, Joanna Mangana, Alessandra Curioni-Fontecedro, et al.
Melanoma Research|December 10, 2024
Rate of response to immune checkpoint inhibitor therapy in patients with conjunctival melanomaBita Esmaeli, Tyler Ogden, Matthew Nichols, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 26, 2018
Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic MelanomaFlorentia Dimitriou, Alexandra V Matter, Joanna Mangana, et al.
European Journal of Dermatology : EJD|April 7, 2020
Sensitivity and specificity of T-cell receptor PCR BIOMED-2 clonality analysis for the diagnosis of cutaneous T-cell lymphomaAnja Moczko, Florentia Dimitriou, Hanna Kresbach, et al.
Oncoimmunology|March 1, 2021
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndromeChristoph Iselin, Yun-Tsan Chang, Tanja Schlaepfer, et al.
Pageof 6